IRIS
VOGRIG, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.312
NA - Nord America 2.792
EU - Europa 1.321
SA - Sud America 605
AF - Africa 95
OC - Oceania 3
Totale 8.128
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.691
SG - Singapore 1.767
CN - Cina 533
BR - Brasile 487
IT - Italia 458
HK - Hong Kong 305
VN - Vietnam 267
FR - Francia 142
DE - Germania 141
RU - Federazione Russa 136
FI - Finlandia 91
IN - India 84
KR - Corea 76
IE - Irlanda 72
BD - Bangladesh 61
AR - Argentina 60
GB - Regno Unito 58
NL - Olanda 43
CA - Canada 39
JP - Giappone 35
MX - Messico 34
UA - Ucraina 31
AT - Austria 29
ES - Italia 27
ID - Indonesia 26
TG - Togo 23
TR - Turchia 23
IQ - Iraq 21
SE - Svezia 20
ZA - Sudafrica 18
EC - Ecuador 17
PK - Pakistan 17
SA - Arabia Saudita 14
PL - Polonia 13
MA - Marocco 11
CO - Colombia 10
KZ - Kazakistan 9
TN - Tunisia 9
TW - Taiwan 9
CL - Cile 8
PT - Portogallo 8
BE - Belgio 7
EG - Egitto 7
JM - Giamaica 7
LT - Lituania 7
NP - Nepal 7
VE - Venezuela 7
CZ - Repubblica Ceca 6
DZ - Algeria 6
PY - Paraguay 6
AZ - Azerbaigian 5
KE - Kenya 5
KG - Kirghizistan 5
MY - Malesia 5
OM - Oman 5
PE - Perù 5
TH - Thailandia 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
CR - Costa Rica 4
HU - Ungheria 4
PH - Filippine 4
BG - Bulgaria 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GR - Grecia 3
JO - Giordania 3
LB - Libano 3
LV - Lettonia 3
RO - Romania 3
SN - Senegal 3
UY - Uruguay 3
AL - Albania 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BO - Bolivia 2
BW - Botswana 2
CI - Costa d'Avorio 2
CU - Cuba 2
HN - Honduras 2
HT - Haiti 2
IL - Israele 2
MD - Moldavia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
SV - El Salvador 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BS - Bahamas 1
BY - Bielorussia 1
CY - Cipro 1
DK - Danimarca 1
GE - Georgia 1
HR - Croazia 1
IR - Iran 1
KH - Cambogia 1
LK - Sri Lanka 1
Totale 8.114
Salva come PNG Salva come JPEG
Città #
Singapore 586
Ashburn 360
Hong Kong 300
Council Bluffs 275
Beijing 233
San Jose 182
Boardman 159
Fairfield 136
Lauterbourg 101
Los Angeles 90
Ho Chi Minh City 86
Seoul 76
Chandler 75
Trieste 75
Hefei 74
Dublin 72
Helsinki 71
Woodbridge 63
Dallas 62
Seattle 61
Houston 58
New York 54
Redondo Beach 54
Hanoi 49
Munich 49
São Paulo 47
Wilmington 46
Santa Clara 45
Milan 43
Cambridge 41
Buffalo 34
Ogden 29
Frankfurt am Main 27
Nuremberg 27
Belluno 25
Orem 24
The Dalles 24
Venezia 24
Dearborn 23
Lomé 23
Princeton 20
Rome 20
Tokyo 20
Ann Arbor 19
Hyderabad 19
Udine 19
Dong Ket 17
Mexico City 17
Amsterdam 16
Chicago 16
Da Nang 16
Montreal 16
Tavagnacco 16
London 15
Rio de Janeiro 15
Jacksonville 14
Lappeenranta 14
Atlanta 13
Chennai 13
Redmond 12
Mumbai 11
Poplar 11
San Francisco 10
Belo Horizonte 9
Biên Hòa 9
Brooklyn 9
Denver 9
Düsseldorf 9
Goiânia 9
Haiphong 9
Vienna 9
Boston 8
Guarulhos 8
Izmir 8
Johannesburg 8
New Delhi 8
Phoenix 8
Porto Alegre 8
San Diego 8
Baghdad 7
Brussels 7
Guayaquil 7
Stockholm 7
Bologna 6
Guangzhou 6
Jakarta 6
Lisbon 6
Naples 6
Norwalk 6
Riyadh 6
Shanghai 6
Shenzhen 6
Sorocaba 6
Toronto 6
Zhengzhou 6
Bishkek 5
Cairo 5
Codroipo 5
Curitiba 5
Fayetteville 5
Totale 4.503
Salva come PNG Salva come JPEG
Nome #
Intra-carotid self-injection of alprazolam: an unusual cause of unilateral multiembolic stroke 209
Tacrolimus-induced severe headache associated with diffuse leukoencephalopathy: Evidence for an immune-mediated pathogenesis 166
Epidemiology of autoimmune versus infectious encephalitis 158
Epilepsia partialis continua revealing idelalisib-associated PML-IRIS: clinical and pathological features 145
Epidemiology of paraneoplastic neurological syndromes: a population-based study 141
Peculiar EEG signatures, ictal drinking and long-term follow-up in anti-LGI1 encephalitis 137
Effect of thymectomy on refractory autoimmune status epilepticus 133
Serum markers as predictors of immune checkpoint inhibitors (ICI) related adverse events in a real-world scenario 128
Seizure specificities in patients with antibody-mediated autoimmune encephalitis 121
Cerebellar Ataxia With Anti-DNER Antibodies: Outcomes and Immunologic Features 120
Back to the future: encephalitis lethargica as an autoimmune disorder? 116
Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination 107
Stroke-Like Presentation of Paraneoplastic Cerebellar Degeneration: a Single-Center Experience and Review of the Literature 105
Sudden unexpected death in epilepsy and ictal asystole in patients with autoimmune encephalitis: a systematic review 101
Central nervous system immune-related disorders after SARS-CoV-2 vaccination: a multicenter study 101
Neurologic Adverse Events of Immune Checkpoint Inhibitors: A Systematic Review 101
Anti-Hu Antibodies in Patients With Neurologic Side Effects of Immune Checkpoint Inhibitors 100
Reply to "Guillain‑Barré syndrome in the COVID‑19 era another occasional cluster?": Insights from two distinct clusters of Guillain–Barré syndrome detected in Europe in the COVID-19 era 100
Anti-CASPR2 clinical phenotypes correlate with HLA and immunological features 98
Consensus Paper: Latent Autoimmune Cerebellar Ataxia (LACA) 95
Central nervous system adverse events of immune checkpoint inhibitors 93
Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes 92
Immunopathogenesis and proposed clinical score for identifying Kelch-like protein-11 encephalitis 92
Stroke in patients with SARS-CoV-2 infection: case series 91
Seizures, Epilepsy, and NORSE Secondary to Autoimmune Encephalitis: A Practical Guide for Clinicians 90
Efficacy of Perampanel in Refractory and Super-Refractory Status Epilepticus with Suspected Inflammatory Etiology: A Case Series 90
Causality in COVID-19-associated stroke: a uniform case definition for use in clinical research 89
Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis 88
Movement disorders in oncology: From clinical features to biomarkers 85
Argonaute Autoantibodies as Biomarkers in Autoimmune Neurologic Diseases 85
Response to Letter to the Editor on the article “Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination” 84
18F-FDG PET brain findings in disease-discordant monozygotic mosaic twins with Cri du Chat (5p-) syndrome 83
Perampanel as add-on therapy in epilepsies with known etiology: A single center experience with long-term follow-up 83
Prediction, prevention, and precision treatment of immune checkpoint inhibitor neurological toxicity using autoantibodies, cytokines, and microbiota 83
Real-Life Evaluation of the MOGAD Diagnostic Criteria: Application Challenges and Discrepancies 82
Paraneoplastic neurological syndromes associated with renal or bladder cancer: case series and PRISMA-IPD systematic review 81
Central nervous system complications associated with immune checkpoint inhibitors 80
Application of the anti-IgLON5 disease composite score to assess severity, clinical course, and mortality in a French cohort 80
Motor neuron involvement in anti-Ma2-associated paraneoplastic neurological syndrome 78
HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome 78
Immune and Genetic Signatures of Breast Carcinomas Triggering Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration 77
SOX1 antibody-related paraneoplastic neurological syndromes: clinical correlates and assessment of laboratory diagnostic techniques 76
Eating reflex epilepsy of presumed autoimmune etiology after SARS-CoV-2 vaccination 75
Anti-Hu-associated paraneoplastic syndromes triggered by immune-checkpoint inhibitor treatment 75
Unclear association between COVID-19 and Guillain-Barré syndrome 75
Bornavirus associated with fatal human encephalitis 74
Neurological adverse events of immune checkpoint inhibitors and the development of paraneoplastic neurological syndromes 74
Cranial Nerve Disorders Associated With Immune Checkpoint Inhibitors 73
Associations between HLA and autoimmune neurological diseases with autoantibodies 73
Adenovirus COVID-19 Vaccines and Guillain–Barré Syndrome with Facial Paralysis 73
Editorial: Neuroglial antibodies: From clinical associations to pathophysiological investigations 72
Bilateral carotid artery dissection in a SARS-CoV-2 infected patient: causality or coincidence? 72
Glial Fibrillary Acidic Protein Autoimmunity: A French Cohort Study 71
Role of LGI1 protein in synaptic transmission: From physiology to pathology 71
Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD 71
A systematic study of stereotypy in epileptic seizures versus psychogenic seizure-like events 70
Cytokine dynamics and targeted immunotherapies in autoimmune encephalitis 68
SARS-CoV-2-related encephalitis with prominent parkinsonism: clinical and FDG-PET correlates in two patients 67
Anti-Ma-associated encephalomyeloradiculopathy in a patient with pleural mesothelioma 67
Reader Response: Prolonged Unconsciousness Following Severe COVID-19 67
Predictors and Clinical Characteristics of Relapses in LGI1-Antibody Encephalitis 66
Paraneoplastic encephalitis: clinically based approach on diagnosis and management 66
Neuroimmune disorders in COVID-19 66
Proceedings of the “International Congress on Structural Epilepsy & Symptomatic Seizures” (STESS, Gothenburg, Sweden, 29–31 March 2023) 65
Stroke in patients with COVID-19: Clinical and neuroimaging characteristics 65
Characterization and management of neurological adverse events during immune-checkpoint inhibitors treatment: an Italian multicentric experience 65
Prognostic Value of Persistent CSF Antibodies at 12 Months in Anti-NMDAR Encephalitis 64
Comparative Study of Paraneoplastic and Nonparaneoplastic Autoimmune Encephalitis With GABA B R Antibodies 64
Prevalence and Trajectories of Post-COVID-19 Neurological Manifestations: A Systematic Review and Meta-Analysis 64
Core cerebrospinal fluid biomarker profile in anti-LGI1 encephalitis 63
Transient Neurological Symptoms Preceding Cerebellar Ataxia with Glutamic Acid Decarboxylase Antibodies 63
Epidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France 63
Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition 62
Neurological outcomes in immune checkpoint inhibitor-related neurotoxicity 61
Distinguishing seizures in autoimmune limbic encephalitis from mesial temporal lobe epilepsy with hippocampal sclerosis: Clues of a temporal plus network 61
Immunomodulation in the acute phase of autoimmune encephalitis 61
Different Genetic Signatures of Small-Cell Lung Cancer Characterize Anti-GABABR and Anti-Hu Paraneoplastic Neurological Syndromes 61
Glioblastoma as differential diagnosis of autoimmune encephalitis 60
Early-Stage Contactin-Associated Protein-like 2 Limbic Encephalitis: Clues for Diagnosis 60
Nystagmus and lower extremity hyperalgesia after colectomy 60
How to diagnose and manage neurological toxicities of immune checkpoint inhibitors: an update 59
Novelties in Autoimmune and Paraneoplastic Cerebellar Ataxias: Twenty Years of Progresses 59
Corticospinal tract hyperintensity in patients with LGI1-antibody encephalitis and other central nervous system disorders with neuroglial antibodies 58
Distinct movement disorders in contactin-associated-protein-like-2 antibody-associated autoimmune encephalitis 58
Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors 58
Revisiting anti-Hu paraneoplastic autoimmunity: phenotypic characterization and cancer diagnosis 58
Immune Checkpoint Inhibitor-Related Cerebellar Toxicity: Clinical Features and Comparison with Paraneoplastic Cerebellar Ataxia 58
Diagnostic yield of commercial immunodots to diagnose paraneoplastic neurologic syndromes 57
Distinctive clinical presentation and pathogenic specificities of anti-AK5 encephalitis 56
Pathophysiology of paraneoplastic and autoimmune encephalitis: genes, infections, and checkpoint inhibitors 55
Prognosis of status epilepticus in adults: recent advances and future directions 54
Probable dysimmune epilepsia partialis continua manifesting as epileptic moving toes syndrome: electroclinical features of a challenging case 52
Postencephalitic epilepsy in children and adults: Etiology matters 51
Dramatic response to delayed treatment with tocilizumab in new-onset refractory status epilepticus 51
Clinical Course of Neurologic Adverse Events Associated With Immune Checkpoint Inhibitors. Focus on Chronic Toxicities 50
Paraneoplastic Neurologic Syndromes Associated With Merkel Cell Carcinoma 48
Familial autoimmunity in neurological patients with GAD65 antibodies: an interview-based study 48
Spatial and Ecological Factors Modulate the Incidence of Anti-NMDAR Encephalitis—A Systematic Review 46
Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies 46
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): Practical recommendations for diagnosis and management 46
Totale 7.958
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.556
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.556
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202133 0 0 0 0 0 0 0 0 0 0 0 33
2021/2022183 9 18 37 6 2 0 13 4 3 20 48 23
2022/2023528 20 18 3 19 176 179 4 8 31 6 17 47
2023/2024343 28 22 5 24 40 18 9 31 44 57 29 36
2024/20252.297 85 140 93 70 71 83 110 104 294 240 404 603
2025/20264.499 349 406 415 552 538 302 556 160 274 352 337 258
Totale 8.536